Bridges Investment Management Inc. raised its position in ARK Genomic Revolution ETF (BATS:ARKG – Free Report) by 3.8% during the second quarter, HoldingsChannel.com reports. The firm owned 14,121 shares of the company’s stock after buying an additional 517 shares during the quarter. Bridges Investment Management Inc.’s holdings in ARK Genomic Revolution ETF were worth $332,000 as of its most recent SEC filing.
Other institutional investors and hedge funds have also recently bought and sold shares of the company. Mercer Global Advisors Inc. ADV increased its holdings in shares of ARK Genomic Revolution ETF by 901.5% during the 2nd quarter. Mercer Global Advisors Inc. ADV now owns 28,943 shares of the company’s stock valued at $680,000 after acquiring an additional 26,053 shares during the last quarter. Headlands Technologies LLC increased its holdings in shares of ARK Genomic Revolution ETF by 5,878.2% during the 2nd quarter. Headlands Technologies LLC now owns 21,163 shares of the company’s stock valued at $497,000 after acquiring an additional 20,809 shares during the last quarter. Choreo LLC acquired a new position in shares of ARK Genomic Revolution ETF during the 2nd quarter valued at about $314,000. Prudential PLC increased its holdings in shares of ARK Genomic Revolution ETF by 15.0% during the 2nd quarter. Prudential PLC now owns 140,170 shares of the company’s stock valued at $3,326,000 after acquiring an additional 18,300 shares during the last quarter. Finally, Ping Capital Management Inc. acquired a new position in shares of ARK Genomic Revolution ETF during the 2nd quarter valued at about $237,000.
ARK Genomic Revolution ETF Trading Down 1.9 %
Shares of BATS ARKG opened at $26.25 on Monday. The firm’s 50 day moving average is $25.81 and its 200-day moving average is $25.76.
ARK Genomic Revolution ETF Profile
The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.
Featured Articles
- Five stocks we like better than ARK Genomic Revolution ETF
- Transportation Stocks Investing
- 3 Stocks That Could Rise on European Bank Interest Rate Cuts
- 5 discounted opportunities for dividend growth investors
- Take Advantage of Village Farms Stock as Cannabis Market Evolves
- How to Evaluate a Stock Before Buying
- MarketBeat Week in Review – 9/16 – 9/20
Want to see what other hedge funds are holding ARKG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ARK Genomic Revolution ETF (BATS:ARKG – Free Report).
Receive News & Ratings for ARK Genomic Revolution ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ARK Genomic Revolution ETF and related companies with MarketBeat.com's FREE daily email newsletter.
